Tandem Diabetes Care (TNDM) Other Non Operating Income (2013 - 2026)
Tandem Diabetes Care's (TNDM) quarterly Other Non Operating Income came in at -$6.9 million in Q2 2026, down 16.14% on a YoY basis from -$8.2 million in Q2 2025, and down 181.05% quarter-over-quarter from -$2.4 million in Q1 2026.
Analysis
Tandem Diabetes Care (TNDM) Other Non Operating Income (2013 - 2026) Analysis & Trends
Tandem Diabetes Care (TNDM) has reported Other Non Operating Income for 14 consecutive years, with -$6.9 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Other Non Operating Income fell 16.14% year-over-year to -$6.9 million; the trailing twelve-month figure through Jun 2026 stood at -$15.2 million (down 399.05% YoY), and the FY2025 full-year result was -$13.0 million, down 279.34% from the prior year.
- Other Non Operating Income eased to -$6.9 million in Q2 2026 per TNDM's latest filing, from -$2.4 million in the prior quarter.
- Across five years, Other Non Operating Income topped out at $4.2 million in Q1 2023 and bottomed at -$6.9 million in Q2 2026.
- Historically, Other Non Operating Income has averaged -$116388.9 across 5 years, with a median of $371000.0 in 2022.
- The sharpest annual moves came in 2023 and 2025: Other Non Operating Income jumped 687.76% in 2023, then sank 704.01% in 2025.
- Over 5 years, Other Non Operating Income stood at $1.7 million in 2022, then jumped by 125.36% to $3.8 million in 2023, then tumbled by 84.05% to $598000.0 in 2024, then plunged by 704.01% to -$3.6 million in 2025, then tumbled by 90.09% to -$6.9 million in 2026.
- According to Business Quant data, Other Non Operating Income over the past three periods registered -$6.9 million, -$2.4 million, and -$3.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.74 Bn | 175.14 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.72 Bn | 122.50 Bn | 1.96 Bn |
| 3 | Medtronic | 116.88 Bn | 108.06 Bn | 6.34 Bn |
| 4 | Stryker | 104.10 Bn | 100.62 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.74 Bn | 63.20 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.85 Bn | 45.60 Bn | 1.35 Bn |
| 7 | Alcon | 33.03 Bn | 31.58 Bn | 1.68 Bn |
| 8 | Dexcom | 32.15 Bn | 30.20 Bn | 830.00 Mn |
| 9 | Steris | 20.63 Bn | 20.15 Bn | 684.20 Mn |
| 10 | Tandem Diabetes Care | 1.27 Bn | 815.53 Mn | 144.78 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -6.87 Mn |
| Mar 31, 2026 | -2.44 Mn |
| Dec 31, 2025 | -3.61 Mn |
| Sep 30, 2025 | -2.28 Mn |
| Jun 30, 2025 | -5.91 Mn |
| Mar 31, 2025 | -1.21 Mn |
| Dec 31, 2024 | 598,000.00 |
| Sep 30, 2024 | 3.48 Mn |
| Jun 30, 2024 | 1.03 Mn |
| Mar 31, 2024 | 2.15 Mn |
| Dec 31, 2023 | 3.75 Mn |
| Sep 30, 2023 | 816,000.00 |
| Jun 30, 2023 | 4.18 Mn |
| Mar 31, 2023 | 4.23 Mn |
| Dec 31, 2022 | 1.66 Mn |
| Sep 30, 2022 | 144,000.00 |
| Jun 30, 2022 | -711,000.00 |
| Mar 31, 2022 | -1.10 Mn |
| Dec 31, 2021 | -1.59 Mn |
| Sep 30, 2021 | -1.87 Mn |